biocon/biocon_technology?

Biocon Technology

Biocon’s manufacturing technologies have helped it transform from a specialty enzymes player to a global provider of biopharmaceuticals spanning small molecules, recombinant proteins, peptides and monoclonal antibodies. These technologies range from large-scale microbial fermentation, chemical synthesis, mammalian cell culture, protein and antibody purification, aseptic formulation to fill-finish.

Biocon’s manufacturing facilities are designed to cGMP standards and are supported by process development and quality control laboratories. They are located at two sites in Bangalore, both of which have been certified by local and international regulatory agencies, including US FDA and EDQM.

Biocon’s human insulin facility has several sophisticated technologies and equipment used for the first time in India. Its biosimilars, such as granulocyte colony stimulating factor (GCSF), streptokinase, reteplase, human growth hormone, etc. are manufactured in a facility equipped to handle both intracellular and extracellular products. Through its subsidiary Biocon Biopharmaceuticals Private Limited, it has established a large-scale, multi-product, cell culture facility.